Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors.

Ortiz-Cuaran S, Scheffler M, Plenker D, Dahmen L, Scheel AH, Fernandez-Cuesta L, Meder L, Lovly CM, Persigehl T, Merkelbach-Bruse S, Bos M, Michels S, Fischer R, Albus K, König K, Schildhaus HU, Fassunke J, Ihle MA, Pasternack H, Heydt C, Becker C, Altmüller J, Ji H, Müller C, Florin A, Heuckmann JM, Nuernberg P, Ansén S, Heukamp LC, Berg J, Pao W, Peifer M, Buettner R, Wolf J, Thomas RK, Sos ML
Clin Cancer Res. 2016 22 (19): 4837-4847

PMID: 27252416 · DOI:10.1158/1078-0432.CCR-15-1915

MeSH Terms (14)

Acrylamides Adenocarcinoma Adenocarcinoma of Lung Aged Aniline Compounds Antineoplastic Agents Drug Resistance, Neoplasm ErbB Receptors Female Humans Lung Neoplasms Male Middle Aged Pyrimidines

Connections (1)

This publication is referenced by other Labnodes entities:

Links